A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension.

Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2009

At a glance

  • Drugs Sapropterin (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors BioMarin Pharmaceutical
  • Most Recent Events

    • 28 Jul 2009 Actual end date changed from Feb 2007 to Dec 2008 as reported by ClinicalTrials.gov.
    • 21 Jan 2008 New trial record.
    • 20 Feb 2007 Results reported; primary endpoint 'Systolic blood pressure' has not been met as reported by BioMarin Pharmaceutical.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top